465 related articles for article (PubMed ID: 19319842)
21. Therapeutic potential of tetrahydrobiopterin for treating vascular and cardiac disease.
Moens AL; Kass DA
J Cardiovasc Pharmacol; 2007 Sep; 50(3):238-46. PubMed ID: 17878750
[TBL] [Abstract][Full Text] [Related]
22. L-arginine, tetrahydrobiopterin, nitric oxide and diabetes.
Hoang HH; Padgham SV; Meininger CJ
Curr Opin Clin Nutr Metab Care; 2013 Jan; 16(1):76-82. PubMed ID: 23164986
[TBL] [Abstract][Full Text] [Related]
23. Maintenance of cellular tetrahydrobiopterin homeostasis.
Kim HL; Park YS
BMB Rep; 2010 Sep; 43(9):584-92. PubMed ID: 20846489
[TBL] [Abstract][Full Text] [Related]
24. Novel therapies targeting vascular endothelium.
Tousoulis D; Antoniades C; Koumallos N; Marinou K; Stefanadi E; Latsios G; Stefanadis C
Endothelium; 2006; 13(6):411-21. PubMed ID: 17169773
[TBL] [Abstract][Full Text] [Related]
25. Augmentation of vascular remodeling by uncoupled endothelial nitric oxide synthase in a mouse model of diabetes mellitus.
Sasaki N; Yamashita T; Takaya T; Shinohara M; Shiraki R; Takeda M; Emoto N; Fukatsu A; Hayashi T; Ikemoto K; Nomura T; Yokoyama M; Hirata K; Kawashima S
Arterioscler Thromb Vasc Biol; 2008 Jun; 28(6):1068-76. PubMed ID: 18403727
[TBL] [Abstract][Full Text] [Related]
26. Mechanisms of Disease: endothelial dysfunction in insulin resistance and diabetes.
Rask-Madsen C; King GL
Nat Clin Pract Endocrinol Metab; 2007 Jan; 3(1):46-56. PubMed ID: 17179929
[TBL] [Abstract][Full Text] [Related]
27. [Defective nitric oxide homeostasis. Common underlying mechanism between insulin resistance, sympathetic overactivity and cardiovascular morbidity and mortality].
Schwab M; Bloch J; Duplain H; Sartori C; Scherrer U
Medicina (B Aires); 2008; 68(3):243-50. PubMed ID: 18689158
[TBL] [Abstract][Full Text] [Related]
28. [Role of tetrahydrobiopterin in the regulation of activity of human placental nitric oxide synthase in normal and pre-eclamptic pregnancies].
Tóth M
Orv Hetil; 2002 Feb; 143(8):391-8. PubMed ID: 11921705
[TBL] [Abstract][Full Text] [Related]
29. Pulmonary hypertension in a GTP-cyclohydrolase 1-deficient mouse.
Nandi M; Miller A; Stidwill R; Jacques TS; Lam AA; Haworth S; Heales S; Vallance P
Circulation; 2005 Apr; 111(16):2086-90. PubMed ID: 15824199
[TBL] [Abstract][Full Text] [Related]
30. L-Leucine and NO-mediated cardiovascular function.
Yang Y; Wu Z; Meininger CJ; Wu G
Amino Acids; 2015 Mar; 47(3):435-47. PubMed ID: 25552397
[TBL] [Abstract][Full Text] [Related]
31. Stimulation of tetrahydrobiopterin synthesis by cyclosporin A in mouse brain microvascular endothelial cells.
Ishii M; Shimizu S; Shiota K; Yamamoto S; Kiuchi Y; Yamamoto T
Int J Biochem Cell Biol; 2002 Sep; 34(9):1134-41. PubMed ID: 12009308
[TBL] [Abstract][Full Text] [Related]
32. Platelet nitric oxide production and IR: relation with obesity and hypertriglyceridemia.
Vignini A; Nanetti L; Moroni C; Testa R; Sirolla C; Marra M; Cenerelli S; Gregori A; Fumelli D; Olivieri F; Mazzanti L; Rabini RA
Nutr Metab Cardiovasc Dis; 2008 Oct; 18(8):553-8. PubMed ID: 18155481
[TBL] [Abstract][Full Text] [Related]
33. Causation, prevention and reversal of vascular endothelial dysfunction.
Lele RD
J Assoc Physicians India; 2007 Sep; 55():643-51. PubMed ID: 18051738
[TBL] [Abstract][Full Text] [Related]
34. Platelet nitric oxide synthesis in uremia and malnutrition: a role for L-arginine supplementation in vascular protection?
Brunini TM; Mendes-Ribeiro AC; Ellory JC; Mann GE
Cardiovasc Res; 2007 Jan; 73(2):359-67. PubMed ID: 17078937
[TBL] [Abstract][Full Text] [Related]
35. Exercise and possible molecular mechanisms of protection from vascular disease and diabetes: the central role of ROS and nitric oxide.
Newsholme P; Homem De Bittencourt PI; O' Hagan C; De Vito G; Murphy C; Krause MS
Clin Sci (Lond); 2009 Nov; 118(5):341-9. PubMed ID: 19922417
[TBL] [Abstract][Full Text] [Related]
36. Review article: diabetes and atherosclerosis--running on a common road.
Federici M; Lauro R
Aliment Pharmacol Ther; 2005 Nov; 22 Suppl 2():11-5. PubMed ID: 16225464
[TBL] [Abstract][Full Text] [Related]
37. [Influence of L-arginine on development of atherosclerosis: what is the therapeutically assured?].
Bode-Böger SM
Dtsch Med Wochenschr; 2005 Mar; 130(11):593-8. PubMed ID: 15761791
[TBL] [Abstract][Full Text] [Related]
38. Amino acids, arginase and nitric oxide in vascular health.
Huynh NN; Chin-Dusting J
Clin Exp Pharmacol Physiol; 2006; 33(1-2):1-8. PubMed ID: 16445692
[TBL] [Abstract][Full Text] [Related]
39. Insulin says NO to cardiovascular disease.
Yu Q; Gao F; Ma XL
Cardiovasc Res; 2011 Feb; 89(3):516-24. PubMed ID: 21051417
[TBL] [Abstract][Full Text] [Related]
40. Insulin resistance, metabolic syndrome and vascular diseases: update on mechanistic linkages.
Lteif A; Mather K
Can J Cardiol; 2004 Aug; 20 Suppl B():66B-76B. PubMed ID: 15309208
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
